<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10547180</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0292309</article-id><article-id pub-id-type="publisher-id">PONE-D-22-30092</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Coronaviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Coronaviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Coronaviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Coronaviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Covid 19</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cell Processes</subject><subj-group><subject>Cell Death</subject><subj-group><subject>Autophagic Cell Death</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Antimalarials</subject><subj-group><subject>Chloroquine</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Replication</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Toxicology</subject><subj-group><subject>Cytotoxicity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Toxicology</subject><subj-group><subject>Cytotoxicity</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>SARS coronavirus</subject><subj-group><subject>SARS CoV 2</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>SARS coronavirus</subject><subj-group><subject>SARS CoV 2</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>SARS coronavirus</subject><subj-group><subject>SARS CoV 2</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>SARS coronavirus</subject><subj-group><subject>SARS CoV 2</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>AMPK inhibitor, compound C, inhibits coronavirus replication <italic toggle="yes">in vitro</italic></article-title><alt-title alt-title-type="running-head">Compound C inhibits coronavirus replication</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Jang</surname><given-names>Minsu</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Park</surname><given-names>Rackhyun</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yamamoto</surname><given-names>Ayane</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Yea-In</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Yeonjeong</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Siyun</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2355-6760</contrib-id><name><surname>Park</surname><given-names>Junsoo</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Division of Biological Science and Technology, Yonsei University, Wonju, Republic of Korea</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Life Science, Yong-In University, Yongin, Republic of Korea</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Parthasarathy</surname><given-names>Krupakar</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Sathyabama Institute of Science and Technology, INDIA</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>NO authors have competing interests.</p></fn><corresp id="cor001">* E-mail: <email>junsoo@yonsei.ac.kr</email></corresp></author-notes><pub-date pub-type="epub"><day>3</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>3</day><month>10</month><year>2023</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>18</volume><issue>10</issue><elocation-id>e0292309</elocation-id><history><date date-type="received"><day>1</day><month>11</month><year>2022</year></date><date date-type="accepted"><day>18</day><month>9</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 Jang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Jang et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0292309.pdf"/><abstract><p>The coronavirus disease (COVID-19) pandemic has resulted in more than six million deaths by October 2022. Vaccines and antivirals for severe acute respiratory syndrome coronavirus 2 are now available; however, more effective antiviral drugs are required for effective treatment. Here, we report that a potent AMP-activated protein kinase (AMPK) inhibitor, compound C/dorsomorphin, inhibits the replication of the human coronavirus OC43 strain (HCoV-OC43). We examined HCoV-OC43 replication in control and AMPK-knockout (KO) cells and found that the virus replication decreased in AMPK-KO cells. Next, we examined the effect of the AMPK inhibitor, compound C on coronavirus replication. Compound C treatment efficiently inhibited the replication and decreased the coronavirus-induced cytotoxicity, further inhibiting autophagy. In addition, treatment with compound C in combination with chloroquine synergistically inhibited coronavirus replication. These results suggest that compound C can be considered as a potential drug candidate for COVID-19.</p></abstract><funding-group><award-group id="award001"><funding-source>
<institution>National Research Foundation of Korea</institution>
</funding-source><award-id>2019R1A2C1006511</award-id><principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2355-6760</contrib-id>
<name><surname>Park</surname><given-names>Junsoo</given-names></name>
</principal-award-recipient></award-group><funding-statement>This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (2019R1A2C1006511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="0"/><page-count count="10"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its <xref rid="sec015" ref-type="sec">Supporting information</xref> files.</meta-value></custom-meta><custom-meta id="outbreaks"><meta-name>Outbreaks</meta-name><meta-value>COVID-19</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its <xref rid="sec015" ref-type="sec">Supporting information</xref> files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The coronavirus disease (COVID-19) pandemic has resulted in millions of deaths owing to the high infectivity and high mortality of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [<xref rid="pone.0292309.ref001" ref-type="bibr">1</xref>]. Although vaccines for SARS-CoV-2 are currently available, effective drugs for COVID-19 are required. Therefore, many researchers have focused on the development of effective treatment for coronavirus diseases using various cell signaling pathways, which are potentially important against coronavirus replication.</p><p>Macroautophagy (autophagy) is an evolutionarily conserved catabolic process that requires lysosomal function, however, its involvement in coronavirus replication is controversial [<xref rid="pone.0292309.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0292309.ref003" ref-type="bibr">3</xref>]. Coronavirus infection results in the formation of double membrane structures containing autophagy proteins, including LC3 and ATG12. Mouse hepatitis virus replication is impaired in ATG5-knockout (KO) cells [<xref rid="pone.0292309.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0292309.ref005" ref-type="bibr">5</xref>]. However, several reports also support that autophagy is not critical for coronavirus replication, as the deletion of key autophagy regulators did not affect coronavirus replication [<xref rid="pone.0292309.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pone.0292309.ref008" ref-type="bibr">8</xref>]. While the role of autophagy in coronavirus replication is unclear, the autophagic flux inhibitors chloroquine and hydroxychloroquine have been reported to efficiently inhibit coronavirus replication [<xref rid="pone.0292309.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0292309.ref010" ref-type="bibr">10</xref>]. They interfere with the replication of SARS-CoV and SARS-CoV-2 <italic toggle="yes">in vitro</italic> by elevating vesicular pH and regulating the glycosylation of angiotensin converting enzyme 2 [<xref rid="pone.0292309.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0292309.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0292309.ref012" ref-type="bibr">12</xref>]. However, clinical trials have not provided consistent and convincing evidence, with studies demonstrating no benefits for the use of chloroquine and hydroxychloroquine in COVID-19 patients [<xref rid="pone.0292309.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0292309.ref014" ref-type="bibr">14</xref>].</p><p>Compound C, also known as dorsomorphin, is a potent AMP-activated protein kinase (AMPK) inhibitor widely used to block AMPK-dependent signaling [<xref rid="pone.0292309.ref015" ref-type="bibr">15</xref>]. Compound C is shown to induce AMPK-independent autophagy by subsequently inhibiting Akt and mTOR [<xref rid="pone.0292309.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0292309.ref017" ref-type="bibr">17</xref>]. In addition to AMPK inhibition, compound C inhibits bone morphogenetic protein (BMP) and VEGF type 2 receptor signaling [<xref rid="pone.0292309.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0292309.ref019" ref-type="bibr">19</xref>] and has anti-proliferative effects on cancer cells, including those in colorectal cancer, skin cancer, and glioma [<xref rid="pone.0292309.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0292309.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0292309.ref021" ref-type="bibr">21</xref>].</p><p>Coronaviruses are classified into alpha, beta, gamma, and delta coronaviruses, where alpha and beta coronaviruses can infect humans. So far, seven coronaviruses have been known to infect human, including human coronavirus 229E (HCoV-229), HCoV-HKU1, HCoV-NL63, HCoV-OC43, SARS-CoV, MERS-CoV and SARS-CoV-2 [<xref rid="pone.0292309.ref022" ref-type="bibr">22</xref>]. SARS-CoV-2 and HCoV-OC43 belong to the beta-coronavirus family [<xref rid="pone.0292309.ref023" ref-type="bibr">23</xref>]. Owing to the strict conditions for dealing with SARS-CoV-2, we used the HCoV-OC43 virus as a surrogate in this report. We aimed to assess the OC43 coronavirus infection in AMPK-KO cells. Further, we used an AMPK inhibitor, compound C, to study coronavirus replication and coronavirus-induced cytotoxicity. We believe that our findings will aid in identifying a novel drug target for coronavirus diseases.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Cell culture and infection</title><p>The HCoV-OC43 virus was obtained from ATCC (Rockville, MD, USA), and Rhabdomyosarcoma (RD) cells were obtained from the Korean Cell Line Bank (KCLB, Seoul, Korea). RD cells were maintained in MEM (Welgene, Seoul, Korea) containing 10% fetal bovine serum (FBS, Thermo Fisher Scientific, Waltham, MA, USA) and 1% penicillin-streptomycin (Welgene). RD cells were infected with HCoV-OC43 as described previously [<xref rid="pone.0292309.ref024" ref-type="bibr">24</xref>]. Cell viability was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [<xref rid="pone.0292309.ref025" ref-type="bibr">25</xref>]. MTT was purchased from USB Corporation (Cleveland, OH, USA). Cells were treated using compound C (Sigma-Aldrich, Saint Louis, MO, USA).</p></sec><sec id="sec004"><title>Plaque formation assay</title><p>To enumerate the virus, RD cells were seeded in a 12-well plate one day prior to the assay. The viral samples were diluted 10-fold in MEM with 2% FBS and added to the corresponding wells and incubated for 1 h at 33&#x000b0;C and 5% CO<sub>2</sub>. Overlay medium was prepared as a mixture of 0.6% agarose in MEM, of which 1 mL was added to each well and the plate was incubated for 5 days. Finally, the cells were fixed with a 10% formaldehyde solution and stained with 1% crystal violet. HCoV-OC43 virus titer in the media was 10<sup>7</sup> PFU/ml.</p></sec><sec id="sec005"><title>Quantitative reverse transcription polymerase chain reaction (RT-PCR)</title><p>Quantitative RT-PCR was used to measure the level of coronavirus RNA in cells and media, as previously described [<xref rid="pone.0292309.ref024" ref-type="bibr">24</xref>]. Briefly, cells and media were harvested, and RNA was extracted using Trizol (Thermo Fisher Scientific) in accordance with the manufacturer&#x02019;s instructions and then subjected to RT-PCR using the StepOnePlus Real-Time PCR System (Thermo Fisher Scientific). HCoV-OC43 RdRp mRNA was amplified using the forward primer <monospace specific-use="no-wrap">5&#x02032;- GATGTAGATGCCCGTCTCG -3&#x02032;</monospace> and reverse primer <monospace specific-use="no-wrap">5&#x02032;- TGTGGCACACGACTACCTTC -3&#x02032;</monospace>. HCoV-OC43 M mRNA was amplified using the forward primer <monospace specific-use="no-wrap">5&#x02032;- ACGGTCACAATA ATACGCGGT -3&#x02032;</monospace> and reverse primer <monospace specific-use="no-wrap">5&#x02032;- GGGTTGATGGCAGTCGGTAA -3&#x02032;</monospace>. The HCoV-OC43 N mRNA was amplified using the forward primer <monospace specific-use="no-wrap">5&#x02032;- AGGATGCCACCAAACCTCAG -3&#x02032;</monospace> and reverse primer <monospace specific-use="no-wrap">5&#x02032;- TGGGGAACTGTGGGTCACTA -3&#x02032;</monospace>. The input RNA was normalized via the amplification of ribosomal protein L4 (RPL4) RNA with the forward primer <monospace specific-use="no-wrap">5&#x02032;-GCTCTGGCCAGGGTGCTTTTG-3&#x02032;</monospace> and reverse primer <monospace specific-use="no-wrap">5&#x02032;-ATGGCGTATCGTTTTTGGGTTGT-3&#x02032;</monospace>.</p></sec><sec id="sec006"><title>Western blotting</title><p>Western blotting was used to measure the level of coronavirus protein in cells and media, as described previously [<xref rid="pone.0292309.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0292309.ref026" ref-type="bibr">26</xref>]. Briefly, cells and media were collected and resuspended in cell lysis buffer (150 mM NaCl, 50 mM HEPES (pH 7.5), and 1% NP40) containing a protease inhibitor cocktail (Roche, Basel, Switzerland). Cell lysates were resolved by SDS-PAGE and transferred to immune-blot PVDF membrane filters (Bio-Rad, Hercules, CA, USA). Viral proteins were detected with a 1:5000 dilution of primary HCoV-OC43 antibody using an ECL Western blotting substrate (Dogen, Seoul, Korea). The images were acquired using the ChemiDoc Imaging System (Bio-Rad). The HCoV-OC43 antibody was purchased from Sigma-Aldrich.</p></sec><sec id="sec007"><title>Immunofluorescence analysis</title><p>To visualize the cells infected with coronavirus, cells were grown on sterilized glass coverslips and infected with coronavirus. The cells were fixed with 4% paraformaldehyde, blocked with 3% bovine serum albumin in PBS, and stained with anti-OC43 antibody (1:1000 dilution). Finally, the cells were stained with Alexa Fluor 488&#x02013;conjugated secondary antibody (Thermo Fisher Scientific) and DAPI. Images were captured using a Carl Zeiss LSM710 confocal microscope (Carl Zeiss, Oberkochen, Germany). Both OC43 positive cells and OC43 negative cells were counted and analyzed to show the percentage of HCoV-OC43 infected cells in each microscopy image.</p></sec><sec id="sec008"><title>Statistical analysi</title><p>The results of western blotting, quantitative RT-PCR, and MTT assay were evaluated by a two-tailed Student&#x02019;s t-test using Excel software (Microsoft, Redmond, WA, USA). Statistical significance was set as <italic toggle="yes">P</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="sec009"><title>Results</title><sec id="sec010"><title>Coronavirus replication is decreased in AMPK-KO cells</title><p>Several studies have suggested that autophagy is involved in coronavirus replication; Thus, we attempted to examine the role of AMPK in coronavirus replication. Previously, we generated AMPK-KO cells and showed that autophagic flux is deregulated in these cells [<xref rid="pone.0292309.ref027" ref-type="bibr">27</xref>]. Here, control and AMPK-KO cells were infected with HCoV-OC43 coronavirus, and western blotting with anti-OC43 antibody was used to examine the level of coronavirus. The level of coronavirus in the cells was significantly decreased in AMPK-KO cells (<xref rid="pone.0292309.g001" ref-type="fig">Fig 1A and 1C</xref>). Moreover, coronavirus in the cell culture media was also dramatically decreased in AMPK-KO cells (<xref rid="pone.0292309.g001" ref-type="fig">Fig 1B and 1D</xref>). Further, we examined the level of coronavirus RNA in the cell culture media using quantitative RT-PCR and found a significant reduction in AMPK-KO cells (<xref rid="pone.0292309.g001" ref-type="fig">Fig 1E</xref>). These results indicate that AMPK is required for efficient coronavirus replication.</p><fig position="float" id="pone.0292309.g001"><object-id pub-id-type="doi">10.1371/journal.pone.0292309.g001</object-id><label>Fig 1</label><caption><title>Coronavirus replication is decreased in AMPK-knockout (KO) cells.</title><p>(A) The expression level of coronavirus proteins in AMPK-KO cells. HEK293T control cells and AMPK-KO cells were infected with the indicated dilutions of HCoV-OC43 coronavirus. Cells were collected after 72 h of infection and equal amount of cell lysates were subjected to western blotting with the indicated antibodies. (B) The expression level of coronavirus proteins in the media of AMPK-KO cells. Media of virus-infected cells were collected and probed with anti-HCoV-OC43 antibody. Coomassie staining of media was used as a loading control. (C and D) The level of OC43 proteins were quantitated and denoted as a graph in cell lysates (C) showing mean &#x000b1; standard error and in media (D) showing mean &#x000b1; standard deviation. Control vs KO cells: *, <italic toggle="yes">P</italic> &#x0003c; 0.05, n = 5. (E) HEK293T control and AMPK-KO cells were infected with coronavirus (10<sup>&#x02212;3</sup> dilution), and RNA was collected from the media. The RNA level of RdRp gene, M gene and N gene was evaluated using quantitative RT-PCR. Control vs KO cells: *, <italic toggle="yes">P</italic> &#x0003c; 0.05, **, <italic toggle="yes">P</italic> &#x0003c; 0.01, ***, <italic toggle="yes">P</italic> &#x0003c; 0.005, n = 4.</p></caption><graphic xlink:href="pone.0292309.g001" position="float"/></fig><p>To assess whether AMPK activity and coronavirus infection contribute to autophagy regulation, we examined the level of autophagy marker expression. Coronavirus infection increased the level of LC3-II protein and p62 (<xref rid="pone.0292309.g001" ref-type="fig">Fig 1A</xref>), which indicated that coronavirus infection affected autophagy. We also found that AMPK-KO cells showed a slightly lower level of p62 protein following coronavirus infection (<xref rid="pone.0292309.g001" ref-type="fig">Fig 1A</xref>).</p></sec><sec id="sec011"><title>Compound C treatment inhibits coronavirus replication</title><p>The replication of coronavirus was decreased in AMPK-KO cells; therefore, we hypothesized that AMPK inhibition by AMPK inhibitor would also decrease the replication. As predicted, AMPK inhibitor, compound C treatment decreased the level of coronavirus protein in the cell culture media and cell lysates in a dose-dependent manner (<xref rid="pone.0292309.g002" ref-type="fig">Fig 2A and 2B</xref>). We further examined the level of coronavirus RNA, which also decreased after compound C treatment in a dose-dependent manner in both cells and culture media (<xref rid="pone.0292309.g002" ref-type="fig">Fig 2C and 2D</xref>). These results indicate that the inhibition of AMPK by compound C affected coronavirus replication.</p><fig position="float" id="pone.0292309.g002"><object-id pub-id-type="doi">10.1371/journal.pone.0292309.g002</object-id><label>Fig 2</label><caption><title>Compound C treatment inhibits coronavirus replication.</title><p>(A) RD cells were infected with coronavirus (10<sup>&#x02212;3</sup> dilution) and incubated with the indicated concentrations of compound C. Cells and media were collected after 72 h of infection and probed with anti-HCoV-OC43 antibody. Ponceau S staining was used as a loading control for media western blot. (B) The expression of coronavirus protein was q uantitated and denoted as a graph. Control vs compound C treated: *, <italic toggle="yes">P</italic> &#x0003c; 0.05, ***, <italic toggle="yes">P</italic> &#x0003c; 0.005, n = 4. (C and D) RD cells were infected with coronavirus, and incubated with the indicated concentration of compound C. After 72 h of infection, RNA was collected from the cells (C) and media (D) and the RNA level of RdRp gene, M gene and N gene was evaluated by quantitative RT-PCR. Control vs compound C treated: *, <italic toggle="yes">P</italic> &#x0003c; 0.05, **, <italic toggle="yes">P</italic> &#x0003c; 0.01, ***, <italic toggle="yes">P</italic> &#x0003c; 0.005, n = 4.</p></caption><graphic xlink:href="pone.0292309.g002" position="float"/></fig></sec><sec id="sec012"><title>Compound C treatment decreases coronavirus cytotoxicity</title><p>We further examined the effects of compound C treatment on coronavirus infection using immunofluorescence staining. HEK293T and RD cells were infected with HCoV-OC43 virus and incubated with compound C, and viral protein expression was assessed using immunofluorescence staining with anti-OC43 antibody. With an increase in the compound C concentration, the number of coronavirus-positive cells decreased significantly, indicating that compound C treatment inhibited coronavirus infections (<xref rid="pone.0292309.g003" ref-type="fig">Fig 3A&#x02013;3C</xref>).</p><fig position="float" id="pone.0292309.g003"><object-id pub-id-type="doi">10.1371/journal.pone.0292309.g003</object-id><label>Fig 3</label><caption><title>Compound C treatment inhibits the coronavirus infection.</title><p>(A) HEK293T cells and RD cells were incubated with coronavirus (10<sup>&#x02212;3</sup> dilution), and with the indicated concentrations of compound C. Cells were fixed 48 h after infection and stained with anti-HCoV-OC43 antibody. Bars: 10 &#x003bc;M. (B and C) Coronavirus infected cells were counted and the percentage of infection was calculated in HEK293T cells (B) and RD cells (C). Control vs compound C treated: ***, <italic toggle="yes">P</italic> &#x0003c; 0.005, n = 13. (D) Compound C treatment induced HCoV-OC43 cytotoxicity. RD cells were infected with mock or HCoV-OC43 and treated with control or compound C followed by agarose overlay. To visualize the cytotoxicity, the infected cells were fixed and stained with crystal violet. (E) RD cells were infected with mock or HCoV-OC43 and incubated with control or compound C for 5 days. Cell viability was measured by MTT assay. ***, <italic toggle="yes">P</italic> &#x0003c; 0.005, n = 4.</p></caption><graphic xlink:href="pone.0292309.g003" position="float"/></fig><p>Since compound C treatment interferes with coronavirus replication, we expected that the cytotoxicity caused by the infection would be decreased by compound C treatment. In a plaque formation assay, while coronavirus infection induced plaque formation, compound C treatment reduced it (<xref rid="pone.0292309.g003" ref-type="fig">Fig 3D</xref>). This suggests that compound C decreases the cytotoxicity of coronavirus.</p><p>Furthermore, examination of cell viability upon coronavirus infection in the presence or absence of compound C showed a significant decrease in cell viability post-infection, which was alleviated with compound C treatment (<xref rid="pone.0292309.g003" ref-type="fig">Fig 3E</xref>). These results indicate that compound C protects cells from the coronavirus-induced cell death.</p></sec><sec id="sec013"><title>Compound C and chloroquine treatments synergistically inhibits coronavirus replication</title><p>As AMPK inhibition interferes with autophagy, we hypothesized that an autophagy and AMPK inhibition may synergistically inhibit coronavirus replication. Toward this, we treated cells with chloroquine, a representative inhibitor of autolysosome formation, and compound C (<xref rid="pone.0292309.g004" ref-type="fig">Fig 4G</xref>). While compound C and chloroquine inhibited the expression of coronavirus protein individually, the co-treatment showed a synergistic effect (<xref rid="pone.0292309.g004" ref-type="fig">Fig 4A and 4B</xref>). Additionally, immunofluorescence staining revealed that co-treatment with compound C and chloroquine synergistically decreased the percentage of coronavirus-infected cells (<xref rid="pone.0292309.g004" ref-type="fig">Fig 4E and 4F</xref>).</p><fig position="float" id="pone.0292309.g004"><object-id pub-id-type="doi">10.1371/journal.pone.0292309.g004</object-id><label>Fig 4</label><caption><title>Combination of compound C (CC) and chloroquine (CQ) treatment synergistically inhibits the coronavirus infection.</title><p>(A) HEK293T cells were incubated with coronavirus (10<sup>&#x02212;3</sup> dilution), and incubated with the indicated concentrations of CC and CQ. Cells were collected 48 h after infection and subject to western blot with anti-HCoV-OC43 antibody. (B) The level of OC43 proteins were quantitated and denoted as a graph. **, <italic toggle="yes">P</italic> &#x0003c; 0.01, ***, <italic toggle="yes">P</italic> &#x0003c; 0.005, n = 3. (C and D) The expression levels of p62 and LC3 were quantitated and denoted as a graph. **, <italic toggle="yes">P</italic> &#x0003c; 0.01, n = 3. (E) HEK293T cells were incubated with coronavirus (10<sup>&#x02212;3</sup> dilution), and incubated with the indicated combinations of CC and CQ. Cells were fixed 48 h after infection and stained with anti-HCoV-OC43 antibody. Bars, 10 &#x003bc;M. (F) Coronavirus infected cells were calculated in HEK293T cells and denote in graph. ***, <italic toggle="yes">P</italic> &#x0003c; 0.005, n = 6. (G) Schematic diagram showing the action of compound C and chloroquine on the autophagy.</p></caption><graphic xlink:href="pone.0292309.g004" position="float"/></fig><p>We also examined the expression of autophagy markers in combination with compound C and chloroquine treatment following coronavirus infection (<xref rid="pone.0292309.g004" ref-type="fig">Fig 4C and 4D</xref>). We measured autophagic flux based on differences in LC3-II protein expression in the presence or absence of chloroquine. The autophagic flux, as determined by the LC3-II protein levels was also decreased in the presence of compound C (<xref rid="pone.0292309.g004" ref-type="fig">Fig 4D</xref>). The graph indicates that compound C treatment reduced the autophagic flux (<xref rid="pone.0292309.g004" ref-type="fig">Fig 4D</xref>).</p></sec></sec><sec sec-type="conclusions" id="sec014"><title>Discussion</title><p>In this study, we examined the effect of compound C/dorsomorphin on the replication of human coronaviruses. Previously, we generated AMPK&#x00251;1-KO cell lines and demonstrated that autophagy initiation and progression were impaired [<xref rid="pone.0292309.ref027" ref-type="bibr">27</xref>]. Here, we used AMPK-KO cells to examine the role of AMPK in coronavirus replication and found it to be an essential factor. We used AMPK-KO cell data to develop potential coronavirus drugs. Next, we tested an AMPK inhibitor, compound C and found that it effectively inhibited coronavirus replication. These results suggest that AMPK plays an important role in coronavirus replication and is a novel drug target for coronavirus disease.</p><p>Compound C induces apoptosis in cancer cells [<xref rid="pone.0292309.ref017" ref-type="bibr">17</xref>], and we also observed slight cytotoxicity at higher concentrations (&#x02265;10 &#x003bc;M). In cell culture experiments, we found that up to 7.5 &#x003bc;M did not show significant cytotoxicity and significantly decreased coronavirus-induced cytotoxicity (<xref rid="pone.0292309.g003" ref-type="fig">Fig 3E</xref>). Although the toxicity of compound C has not been fully examined in animals, recent studies have shown that up to 15 mg/kg of compound C can be injected into mouse [<xref rid="pone.0292309.ref028" ref-type="bibr">28</xref>]. These concentrations can inhibit coronavirus replication; therefore, compound C can potentially be useful for treating coronavirus disease <italic toggle="yes">in vivo</italic>. Although compound C is reported to show an inhibitory effect on several kinases other than AMPK, currently, no AMPK-specific inhibitor is available, and the development of more specific inhibitors would be helpful in treating coronavirus-related diseases [<xref rid="pone.0292309.ref029" ref-type="bibr">29</xref>].</p><p>In addition, we demonstrated that co-treatment with compound C and chloroquine collectively inhibited coronavirus replication (<xref rid="pone.0292309.g004" ref-type="fig">Fig 4</xref>). The dose of compound C and chloroquine can be further decreased during the administration of both the drugs, where the cytotoxicity can also be reduced. Further studies, including animal experiments, should be performed to validate the efficacy of compound C and chloroquine <italic toggle="yes">in vivo</italic>.</p><p>In this report, we demonstrated that AMPK-KO and an AMPK inhibitor downregulated coronavirus replication. Recent reports have highlighted the requirement of autophagy for efficient replication of coronavirus and that autophagic flux can be blocked by coronavirus protein expression [<xref rid="pone.0292309.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0292309.ref030" ref-type="bibr">30</xref>]. Interestingly, we showed that coronavirus infection induced the expression of p62 indicating that autophagic flux was suppressed (<xref rid="pone.0292309.g001" ref-type="fig">Fig 1A</xref>). Co-treatment with compound C and chloroquine efficiently blocked coronavirus replication where compound C can inhibit autophagy initiation, and chloroquine treatment interferes with autophagic flux. This co-treatment efficiently reduced autophagy (<xref rid="pone.0292309.g004" ref-type="fig">Fig 4G</xref>). Moreover, these findings suggest that autophagy inhibition contributes to the reduction in coronavirus replication. Both the drugs affected different pathways, therefore, there may be additional signaling pathways that regulate coronavirus replication, which needs to be further elucidated.</p><p>HCoV-OC43, which belongs to the beta coronavirus family like SARS-CoV-2, induces a mild disease [<xref rid="pone.0292309.ref022" ref-type="bibr">22</xref>]. Therefore, HCoV-OC43 has been widely used to study the coronavirus [<xref rid="pone.0292309.ref024" ref-type="bibr">24</xref>]. Here, we used HCoV-OC43 as a model system to study SARS-CoV-2, and further study is required to examine and validate the effect of compound C on SARS-CoV-2 replication. Moreover, the current study was performed <italic toggle="yes">in vitro</italic>, and animal experiments should be performed to validate this effect <italic toggle="yes">in vivo</italic>.</p></sec><sec id="sec015" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0292309.s001" position="float" content-type="local-data"><label>S1 Raw images</label><caption><p>(PDF)</p></caption><media xlink:href="pone.0292309.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pone.0292309.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Baud</surname><given-names>D</given-names></name>, <name><surname>Qi</surname><given-names>X</given-names></name>, <name><surname>Nielsen-Saines</surname><given-names>K</given-names></name>, <name><surname>Musso</surname><given-names>D</given-names></name>, <name><surname>Pomar</surname><given-names>L</given-names></name>, <name><surname>Favre</surname><given-names>G</given-names></name>. <article-title>Real estimates of mortality following COVID-19 infection</article-title>. <source>Lancet Infect Dis</source>. <year>2020</year>;<volume>20</volume>(<issue>7</issue>):<fpage>773</fpage>. Epub 2020/03/17. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30195-X</pub-id> .<?supplied-pmid 32171390?><pub-id pub-id-type="pmid">32171390</pub-id></mixed-citation></ref><ref id="pone.0292309.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>K</given-names></name>, <name><surname>McGrath</surname><given-names>ME</given-names></name>, <name><surname>Hu</surname><given-names>Z</given-names></name>, <name><surname>Ariannejad</surname><given-names>S</given-names></name>, <name><surname>Weston</surname><given-names>S</given-names></name>, <name><surname>Frieman</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Coronavirus interactions with the cellular autophagy machinery</article-title>. <source>Autophagy</source>. <year>2020</year>;<volume>16</volume>(<issue>12</issue>):<fpage>2131</fpage>&#x02013;<lpage>9</lpage>. Epub 2020/09/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/15548627.2020.1817280</pub-id> .<?supplied-pmid 32964796?><pub-id pub-id-type="pmid">32964796</pub-id></mixed-citation></ref><ref id="pone.0292309.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Z</given-names></name>, <name><surname>Lu</surname><given-names>K</given-names></name>, <name><surname>Mao</surname><given-names>B</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>, <name><surname>Trilling</surname><given-names>M</given-names></name>, <name><surname>Huang</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>The interplay between emerging human coronavirus infections and autophagy</article-title>. <source>Emerg Microbes Infect</source>. <year>2021</year>;<volume>10</volume>(<issue>1</issue>):<fpage>196</fpage>&#x02013;<lpage>205</lpage>. Epub 2021/01/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/22221751.2021.1872353</pub-id> .<?supplied-pmid 33399028?><pub-id pub-id-type="pmid">33399028</pub-id></mixed-citation></ref><ref id="pone.0292309.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Prentice</surname><given-names>E</given-names></name>, <name><surname>McAuliffe</surname><given-names>J</given-names></name>, <name><surname>Lu</surname><given-names>X</given-names></name>, <name><surname>Subbarao</surname><given-names>K</given-names></name>, <name><surname>Denison</surname><given-names>MR</given-names></name>. <article-title>Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins</article-title>. <source>J Virol</source>. <year>2004</year>;<volume>78</volume>(<issue>18</issue>):<fpage>9977</fpage>&#x02013;<lpage>86</lpage>. Epub 2004/08/28. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JVI.78.18.9977-9986.2004</pub-id> .<?supplied-pmid 15331731?><pub-id pub-id-type="pmid">15331731</pub-id></mixed-citation></ref><ref id="pone.0292309.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Prentice</surname><given-names>E</given-names></name>, <name><surname>Jerome</surname><given-names>WG</given-names></name>, <name><surname>Yoshimori</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>N</given-names></name>, <name><surname>Denison</surname><given-names>MR</given-names></name>. <article-title>Coronavirus replication complex formation utilizes components of cellular autophagy</article-title>. <source>J Biol Chem</source>. <year>2004</year>;<volume>279</volume>(<issue>11</issue>):<fpage>10136</fpage>&#x02013;<lpage>41</lpage>. Epub 2003/12/31. <comment>doi: </comment><pub-id pub-id-type="doi">10.1074/jbc.M306124200</pub-id> .<?supplied-pmid 14699140?><pub-id pub-id-type="pmid">14699140</pub-id></mixed-citation></ref><ref id="pone.0292309.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Z</given-names></name>, <name><surname>Thackray</surname><given-names>LB</given-names></name>, <name><surname>Miller</surname><given-names>BC</given-names></name>, <name><surname>Lynn</surname><given-names>TM</given-names></name>, <name><surname>Becker</surname><given-names>MM</given-names></name>, <name><surname>Ward</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Coronavirus replication does not require the autophagy gene ATG5</article-title>. <source>Autophagy</source>. <year>2007</year>;<volume>3</volume>(<issue>6</issue>):<fpage>581</fpage>&#x02013;<lpage>5</lpage>. Epub 2007/08/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.4161/auto.4782</pub-id> .<?supplied-pmid 17700057?><pub-id pub-id-type="pmid">17700057</pub-id></mixed-citation></ref><ref id="pone.0292309.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Reggiori</surname><given-names>F</given-names></name>, <name><surname>Monastyrska</surname><given-names>I</given-names></name>, <name><surname>Verheije</surname><given-names>MH</given-names></name>, <name><surname>Cali</surname><given-names>T</given-names></name>, <name><surname>Ulasli</surname><given-names>M</given-names></name>, <name><surname>Bianchi</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication</article-title>. <source>Cell Host Microbe</source>. <year>2010</year>;<volume>7</volume>(<issue>6</issue>):<fpage>500</fpage>&#x02013;<lpage>8</lpage>. Epub 2010/06/15. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.chom.2010.05.013</pub-id> .<?supplied-pmid 20542253?><pub-id pub-id-type="pmid">20542253</pub-id></mixed-citation></ref><ref id="pone.0292309.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Schneider</surname><given-names>M</given-names></name>, <name><surname>Ackermann</surname><given-names>K</given-names></name>, <name><surname>Stuart</surname><given-names>M</given-names></name>, <name><surname>Wex</surname><given-names>C</given-names></name>, <name><surname>Protzer</surname><given-names>U</given-names></name>, <name><surname>Schatzl</surname><given-names>HM</given-names></name>, <etal>et al</etal>. <article-title>Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain</article-title>. <source>J Virol</source>. <year>2012</year>;<volume>86</volume>(<issue>18</issue>):<fpage>10112</fpage>&#x02013;<lpage>22</lpage>. Epub 2012/07/13. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JVI.01001-12</pub-id> .<?supplied-pmid 22787216?><pub-id pub-id-type="pmid">22787216</pub-id></mixed-citation></ref><ref id="pone.0292309.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Vincent</surname><given-names>MJ</given-names></name>, <name><surname>Bergeron</surname><given-names>E</given-names></name>, <name><surname>Benjannet</surname><given-names>S</given-names></name>, <name><surname>Erickson</surname><given-names>BR</given-names></name>, <name><surname>Rollin</surname><given-names>PE</given-names></name>, <name><surname>Ksiazek</surname><given-names>TG</given-names></name>, <etal>et al</etal>. <article-title>Chloroquine is a potent inhibitor of SARS coronavirus infection and spread</article-title>. <source>Virol J</source>. <year>2005</year>;<volume>2</volume>:<fpage>69</fpage>. Epub 2005/08/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1743-422X-2-69</pub-id> .<?supplied-pmid 16115318?><pub-id pub-id-type="pmid">16115318</pub-id></mixed-citation></ref><ref id="pone.0292309.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Maity</surname><given-names>S</given-names></name>, <name><surname>Saha</surname><given-names>A</given-names></name>. <article-title>Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection</article-title>. <source>Front Microbiol</source>. <year>2021</year>;<volume>12</volume>:<fpage>675419</fpage>. Epub 2021/06/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fmicb.2021.675419</pub-id> .<?supplied-pmid 34054782?><pub-id pub-id-type="pmid">34054782</pub-id></mixed-citation></ref><ref id="pone.0292309.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Cao</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</article-title>. <source>Cell Res</source>. <year>2020</year>;<volume>30</volume>(<issue>3</issue>):<fpage>269</fpage>&#x02013;<lpage>71</lpage>. Epub 2020/02/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41422-020-0282-0</pub-id> .<?supplied-pmid 32020029?><pub-id pub-id-type="pmid">32020029</pub-id></mixed-citation></ref><ref id="pone.0292309.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>N</given-names></name>, <name><surname>Shen</surname><given-names>HM</given-names></name>. <article-title>Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19</article-title>. <source>Int J Biol Sci</source>. <year>2020</year>;<volume>16</volume>(<issue>10</issue>):<fpage>1724</fpage>&#x02013;<lpage>31</lpage>. Epub 2020/04/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.7150/ijbs.45498</pub-id> .<?supplied-pmid 32226290?><pub-id pub-id-type="pmid">32226290</pub-id></mixed-citation></ref><ref id="pone.0292309.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>MX</given-names></name>, <name><surname>Lu</surname><given-names>GD</given-names></name>, <name><surname>Shen</surname><given-names>HM</given-names></name>, <name><surname>Zhou</surname><given-names>J</given-names></name>. <article-title>Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery</article-title>. <source>Int J Biol Sci</source>. <year>2021</year>;<volume>17</volume>(<issue>6</issue>):<fpage>1538</fpage>&#x02013;<lpage>46</lpage>. Epub 2021/04/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.7150/ijbs.59547</pub-id> .<?supplied-pmid 33907517?><pub-id pub-id-type="pmid">33907517</pub-id></mixed-citation></ref><ref id="pone.0292309.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Sands</surname><given-names>K</given-names></name>, <name><surname>Wenzel</surname><given-names>R</given-names></name>, <name><surname>McLean</surname><given-names>L</given-names></name>, <name><surname>Korwek</surname><given-names>K</given-names></name>, <name><surname>Roach</surname><given-names>J</given-names></name>, <name><surname>Miller</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19</article-title>. <source>Int J Infect Dis</source>. <year>2021</year>;<volume>104</volume>:<fpage>34</fpage>&#x02013;<lpage>40</lpage>. Epub 2020/12/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijid.2020.12.060</pub-id> .<?supplied-pmid 33359949?><pub-id pub-id-type="pmid">33359949</pub-id></mixed-citation></ref><ref id="pone.0292309.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>G</given-names></name>, <name><surname>Myers</surname><given-names>R</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Shen</surname><given-names>X</given-names></name>, <name><surname>Fenyk-Melody</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Role of AMP-activated protein kinase in mechanism of metformin action</article-title>. <source>J Clin Invest</source>. <year>2001</year>;<volume>108</volume>(<issue>8</issue>):<fpage>1167</fpage>&#x02013;<lpage>74</lpage>. Epub 2001/10/17. <comment>doi: </comment><pub-id pub-id-type="doi">10.1172/JCI13505</pub-id> .<?supplied-pmid 11602624?><pub-id pub-id-type="pmid">11602624</pub-id></mixed-citation></ref><ref id="pone.0292309.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Vucicevic</surname><given-names>L</given-names></name>, <name><surname>Misirkic</surname><given-names>M</given-names></name>, <name><surname>Janjetovic</surname><given-names>K</given-names></name>, <name><surname>Vilimanovich</surname><given-names>U</given-names></name>, <name><surname>Sudar</surname><given-names>E</given-names></name>, <name><surname>Isenovic</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway</article-title>. <source>Autophagy</source>. <year>2011</year>;<volume>7</volume>(<issue>1</issue>):<fpage>40</fpage>&#x02013;<lpage>50</lpage>. Epub 2010/10/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.4161/auto.7.1.13883</pub-id> .<?supplied-pmid 20980833?><pub-id pub-id-type="pmid">20980833</pub-id></mixed-citation></ref><ref id="pone.0292309.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>WL</given-names></name>, <name><surname>Perillo</surname><given-names>W</given-names></name>, <name><surname>Liou</surname><given-names>D</given-names></name>, <name><surname>Marambaud</surname><given-names>P</given-names></name>, <name><surname>Wang</surname><given-names>P</given-names></name>. <article-title>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</article-title>. <source>J Surg Oncol</source>. <year>2012</year>;<volume>106</volume>(<issue>6</issue>):<fpage>680</fpage>&#x02013;<lpage>8</lpage>. Epub 2012/06/08. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jso.23184</pub-id> .<?supplied-pmid 22674626?><pub-id pub-id-type="pmid">22674626</pub-id></mixed-citation></ref><ref id="pone.0292309.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Hao</surname><given-names>J</given-names></name>, <name><surname>Ho</surname><given-names>JN</given-names></name>, <name><surname>Lewis</surname><given-names>JA</given-names></name>, <name><surname>Karim</surname><given-names>KA</given-names></name>, <name><surname>Daniels</surname><given-names>RN</given-names></name>, <name><surname>Gentry</surname><given-names>PR</given-names></name>, <etal>et al</etal>. <article-title>In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors</article-title>. <source>ACS Chem Biol</source>. <year>2010</year>;<volume>5</volume>(<issue>2</issue>):<fpage>245</fpage>&#x02013;<lpage>53</lpage>. Epub 2009/12/22. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/cb9002865</pub-id> .<?supplied-pmid 20020776?><pub-id pub-id-type="pmid">20020776</pub-id></mixed-citation></ref><ref id="pone.0292309.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Hao</surname><given-names>J</given-names></name>, <name><surname>Daleo</surname><given-names>MA</given-names></name>, <name><surname>Murphy</surname><given-names>CK</given-names></name>, <name><surname>Yu</surname><given-names>PB</given-names></name>, <name><surname>Ho</surname><given-names>JN</given-names></name>, <name><surname>Hu</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells</article-title>. <source>PLoS One</source>. <year>2008</year>;<volume>3</volume>(<issue>8</issue>):<fpage>e2904</fpage>. Epub 2008/08/07. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0002904</pub-id> .<?supplied-pmid 18682835?><pub-id pub-id-type="pmid">18682835</pub-id></mixed-citation></ref><ref id="pone.0292309.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>SW</given-names></name>, <name><surname>Wu</surname><given-names>CY</given-names></name>, <name><surname>Wang</surname><given-names>YT</given-names></name>, <name><surname>Kao</surname><given-names>JK</given-names></name>, <name><surname>Lin</surname><given-names>CC</given-names></name>, <name><surname>Chang</surname><given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2013</year>;<volume>267</volume>(<issue>1</issue>):<fpage>113</fpage>&#x02013;<lpage>24</lpage>. Epub 2013/01/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.taap.2012.12.016</pub-id> .<?supplied-pmid 23274516?><pub-id pub-id-type="pmid">23274516</pub-id></mixed-citation></ref><ref id="pone.0292309.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Chhipa</surname><given-names>RR</given-names></name>, <name><surname>Nakano</surname><given-names>I</given-names></name>, <name><surname>Dasgupta</surname><given-names>B</given-names></name>. <article-title>The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent</article-title>. <source>Mol Cancer Ther</source>. <year>2014</year>;<volume>13</volume>(<issue>3</issue>):<fpage>596</fpage>&#x02013;<lpage>605</lpage>. Epub 2014/01/15. <comment>doi: </comment><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-13-0579</pub-id> .<?supplied-pmid 24419061?><pub-id pub-id-type="pmid">24419061</pub-id></mixed-citation></ref><ref id="pone.0292309.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>KG</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Lipkin</surname><given-names>WI</given-names></name>, <name><surname>Holmes</surname><given-names>EC</given-names></name>, <name><surname>Garry</surname><given-names>RF</given-names></name>. <article-title>The proximal origin of SARS-CoV-2</article-title>. <source>Nat Med</source>. <year>2020</year>;<volume>26</volume>(<issue>4</issue>):<fpage>450</fpage>&#x02013;<lpage>2</lpage>. Epub 2020/04/15. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41591-020-0820-9</pub-id> countermeasures to emerging viruses.<?supplied-pmid 32284615?><pub-id pub-id-type="pmid">32284615</pub-id></mixed-citation></ref><ref id="pone.0292309.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Velavan</surname><given-names>TP</given-names></name>, <name><surname>Meyer</surname><given-names>CG</given-names></name>. <article-title>The COVID-19 epidemic</article-title>. <source>Trop Med Int Health</source>. <year>2020</year>;<volume>25</volume>(<issue>3</issue>):<fpage>278</fpage>&#x02013;<lpage>80</lpage>. Epub 2020/02/14. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/tmi.13383</pub-id> .<?supplied-pmid 32052514?><pub-id pub-id-type="pmid">32052514</pub-id></mixed-citation></ref><ref id="pone.0292309.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Jang</surname><given-names>M</given-names></name>, <name><surname>Park</surname><given-names>R</given-names></name>, <name><surname>Park</surname><given-names>YI</given-names></name>, <name><surname>Cha</surname><given-names>YE</given-names></name>, <name><surname>Yamamoto</surname><given-names>A</given-names></name>, <name><surname>Lee</surname><given-names>JI</given-names></name>, <etal>et al</etal>. <article-title>EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2021</year>;<volume>547</volume>:<fpage>23</fpage>&#x02013;<lpage>8</lpage>. Epub 2021/02/16. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bbrc.2021.02.016</pub-id> .<?supplied-pmid 33588235?><pub-id pub-id-type="pmid">33588235</pub-id></mixed-citation></ref><ref id="pone.0292309.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>R</given-names></name>, <name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Jang</surname><given-names>M</given-names></name>, <name><surname>Jo</surname><given-names>D</given-names></name>, <name><surname>Park</surname><given-names>YI</given-names></name>, <name><surname>Namkoong</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>LNX1 contributes to tumor growth by down-regulating p53 stability</article-title>. <source>FASEB J</source>. <year>2019</year>;<volume>33</volume>(<issue>12</issue>):<fpage>13216</fpage>&#x02013;<lpage>27</lpage>. Epub 2019/09/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.1096/fj.201900366R</pub-id> .<?supplied-pmid 31533005?><pub-id pub-id-type="pmid">31533005</pub-id></mixed-citation></ref><ref id="pone.0292309.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>R</given-names></name>, <name><surname>Jang</surname><given-names>M</given-names></name>, <name><surname>Park</surname><given-names>YI</given-names></name>, <name><surname>Park</surname><given-names>Y</given-names></name>, <name><surname>Jung</surname><given-names>W</given-names></name>, <name><surname>Park</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model</article-title>. <source>Viruses</source>. <year>2021</year>;<volume>13</volume>(<issue>12</issue>). Epub 2021/12/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/v13122533</pub-id> .<?supplied-pmid 34960802?><pub-id pub-id-type="pmid">34960802</pub-id></mixed-citation></ref><ref id="pone.0292309.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Jang</surname><given-names>M</given-names></name>, <name><surname>Park</surname><given-names>R</given-names></name>, <name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Namkoong</surname><given-names>S</given-names></name>, <name><surname>Jo</surname><given-names>D</given-names></name>, <name><surname>Huh</surname><given-names>YH</given-names></name>, <etal>et al</etal>. <article-title>AMPK contributes to autophagosome maturation and lysosomal fusion</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>12637</fpage>. Epub 2018/08/25. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-018-30977-7</pub-id> .<?supplied-pmid 30140075?><pub-id pub-id-type="pmid">30140075</pub-id></mixed-citation></ref><ref id="pone.0292309.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Dai</surname><given-names>RY</given-names></name>, <name><surname>Zhao</surname><given-names>XF</given-names></name>, <name><surname>Li</surname><given-names>JJ</given-names></name>, <name><surname>Chen</surname><given-names>R</given-names></name>, <name><surname>Luo</surname><given-names>ZL</given-names></name>, <name><surname>Yu</surname><given-names>LX</given-names></name>, <etal>et al</etal>. <article-title>Implication of transcriptional repression in compound C-induced apoptosis in cancer cells</article-title>. <source>Cell Death Dis</source>. <year>2013</year>;<volume>4</volume>(<issue>10</issue>):<fpage>e883</fpage>. Epub 2013/10/26. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/cddis.2013.419</pub-id> .<?supplied-pmid 24157877?><pub-id pub-id-type="pmid">24157877</pub-id></mixed-citation></ref><ref id="pone.0292309.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Dasgupta</surname><given-names>B</given-names></name>, <name><surname>Seibel</surname><given-names>W</given-names></name>. <article-title>Compound C/Dorsomorphin: Its Use and Misuse as an AMPK Inhibitor</article-title>. <source>Methods Mol Biol</source>. <year>2018</year>;<volume>1732</volume>:<fpage>195</fpage>&#x02013;<lpage>202</lpage>. Epub 2018/02/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/978-1-4939-7598-3_12</pub-id> .<?supplied-pmid 29480476?><pub-id pub-id-type="pmid">29480476</pub-id></mixed-citation></ref><ref id="pone.0292309.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Shang</surname><given-names>C</given-names></name>, <name><surname>Zhuang</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Zhu</surname><given-names>Y</given-names></name>, <name><surname>Lu</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues</article-title>. <source>J Virol</source>. <year>2021</year>;<volume>95</volume>(<issue>24</issue>):<fpage>e0153721</fpage>. Epub 2021/09/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JVI.01537-21</pub-id> .<?supplied-pmid 34550769?><pub-id pub-id-type="pmid">34550769</pub-id></mixed-citation></ref></ref-list></back></article>